|
1
|
Adamia N, Jorjoliani L, Khachapuridze D,
Katamadze N and Chkuaseli N: Allergic diseases and asthma in
adolescents. Georgian Med News. 58–62. 2015.PubMed/NCBI
|
|
2
|
Gotoh M: Allergen immunotherapy for
allergic rhinitis. Arerugi. 64:693–699. 2015.(In Japanese).
PubMed/NCBI
|
|
3
|
Ma C, Ma Z, Liao XL, Liu J, Fu Q and Ma S:
Immunoregulatory effects of glycyrrhizic acid exerts anti-asthmatic
effects via modulation of Th1/Th2 cytokines and enhancement of
CD4(+)CD25(+)Foxp3+ regulatory T cells in ovalbumin-sensitized
mice. J Ethnopharmacol. 148:755–762. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ku CJ, Lim KC, Kalantry S, Maillard I,
Engel JD and Hosoya T: A monoallelic-to-biallelic T-cell
transcriptional switch regulates GATA3 abundance. Genes Dev.
29:1930–1941. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Han LN, Guo SL, Li TL, Ding GL, Zhang YJ
and Ma JL: Effect of immune modulation therapy on cardiac function
and T-bet/GATA-3 gene expression in aging male patients with
chronic cardiac insufficiency. Immunotherapy. 5:143–153. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sanchez AM, Zhu J, Huang X and Yang Y: The
development and function of memory regulatory T cells after acute
viral infections. J Immunol. 189:2805–2814. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lloyd CM and Hawrylowicz CM: Regulatory T
cells in asthma. Immunity. 31:438–449. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Z, Lin F, Gao Y, Li Z, Zhang J, Xing
Y, Deng Z, Yao Z, Tsun A and Li B: FOXP3 and RORγt: Transcriptional
regulation of Treg and Th17. Int Immunopharmacol. 11:536–542. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Korn T, Bettelli E, Oukka M and Kuchroo
VK: IL-17 and Th17 cells. Annu Rev Immunol. 27:485–517. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang XO, Panopoulos AD, Nurieva R, Chang
SH, Wang D, Watowich SS and Dong C: STAT3 regulates
cytokine-mediated generation of inflammatory helper T cells. J Biol
Chem. 282:9358–9363. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo H and Liu MP: Mechanism of traditional
Chinese medicine in the treatment of allergic rhinitis. Chin Med J
(Engl). 126:756–760. 2013.PubMed/NCBI
|
|
12
|
Wang B and Chen MZ: Astragaloside IV
possesses antiarthritic effect by preventing interleukin 1β-induced
joint inflammation and cartilage damage. Arch Pharm Res.
37:793–802. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang LF, Yao YM, Li JF, Zhang SW, Li WX,
Dong N, Yu Y and Sheng ZY: The effect of Astragaloside IV on immune
function of regulatory T cell mediated by high mobility group box 1
protein in vitro. Fitoterapia. 83:1514–1522. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiu YY, Zhu JX, Bian T, Gao F, Qian XF, Du
Q, Yuan MY, Sun H, Shi LZ and Yu MH: Protective effects of
astragaloside IV against ovalbumin-induced lung inflammation are
regulated/mediated by T-bet/GATA-3. Pharmacology. 94:51–59. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao J, Yang P, Li F, Tao L, Ding H, Rui
Y, Cao Z and Zhang W: Therapeutic effects of astragaloside IV on
myocardial injuries: Multi-target identification and network
analysis. PLoS One. 7:e449382012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li M, Qu YZ, Zhao ZW, Wu SX, Liu YY, Wei
XY, Gao L and Gao GD: Astragaloside IV protects against focal
cerebral ischemia/reperfusion injury correlating to suppression of
neutrophils adhesion-related molecules. Neurochem Int. 60:458–465.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen SM, Tsai YS, Lee SW, Liu YH, Liao SK,
Chang WW and Tsai PJ: Astragalus membranaceus modulates Th1/2
immune balance and activates PPARγ in a murine asthma model.
Biochem Cell Biol. 92:397–405. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hiromura Y, Kishida T, Nakano H, Hama T,
Imanishi J, Hisa Y and Mazda O: IL-21 administration into the
nostril alleviates murine allergic rhinitis. J Immunol.
179:7157–7165. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dao-jun X: Studies on the effects of
Freud's adjuvant and aluminum hydroxide adjuvant on Tregs and
CD4+T cell relative genes in spleen of mice. PhD
thesisHunan Agricultural University 2010, (In Chinese).
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method: Methods. 25:402–408. 2001.
|
|
21
|
Chen SM, Tsai YS, Lee SW, Liu YH, Liao SK,
Chang WW and Tsai PJ: Astragalus membranaceus modulates Th1/2
immune balance and activates PPARγ in a murine asthma model.
Biochem Cell Biol. 92:397–405. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mandhane SN, Shah JH and Thennati R:
Allergic rhinitis: An update on disease, present treatments and
future prospects. Int Immunopharmacol. 11:1646–1662. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen J, Ke X, Hong S, Zeng Q, Liang C, Li
T and Tang A: Epidemiological features of allergic rhinitis in four
major cities in western China. J Huazhong Univ Sci Technolog Med
Sci. 31:433–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eid N, Morton R, Olds B, Clark P, Sheikh S
and Looney S: Decreased morning serum cortisol levels in children
with asthma treated with inhaled fluticasone propionate.
Pediatrics. 109:217–221. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Klimek L, Mullol J, Hellings P, Gevaert P,
Mösges R and Fokkens W: Recent pharmacological developments in the
treatment of perennial and persistent allergic rhinitis. Expert
Opin Pharmacother. 17:657–669. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Keith PK, Koch C, Djandji M, Bouchard J,
Psaradellis E, Sampalis JS, Schellenberg RR and McIvor RA:
Montelukast as add-on therapy with inhaled corticosteroids alone or
inhaled corticosteroids and long-acting beta-2-agonists in the
management of patients diagnosed with asthma and concurrent
allergic rhinitis (the RADAR trial). Can Respir J. 16 Suppl
A:17A–31A. 2009.(In English, French). View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jin HL, W LM, Luo QL, Li B, Du YJ, Lv YB
and Dong JC: Effects of astragaloside IV on Th2 lymphocyte D 10. G
4.1 in vitro. Chinese Pharmacological Bulletin. 30:1508–1513.
2014.(In Chinese).
|
|
28
|
Juneja L and Parmar HS: Ovalbumin induced
allergic rhinitis and development of prediabetes to rats: Possible
role of Th2 cytokines. Inflamm Allergy Drug Targets. 12:199–205.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takhar P, Smurthwaite L, Coker HA, Fear
DJ, Banfield GK, Carr VA, Durham SR and Gould HJ: Allergen drives
class switching to IgE in the nasal mucosa in allergic rhinitis. J
Immunol. 174:5024–5032. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shang XZ, Armstrong J, Yang GY, Volk A, Li
J, Griswold DE, Emmell E and Li L: Regulation of antigen-specific
versus by-stander IgE production after antigen sensitization. Cell
Immunol. 229:106–116. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Melli LC, do Carmo-Rodrigues MS,
Araújo-Filho HB, Solé D and de Morais MB: Intestinal microbiota and
allergic diseases: A systematic review. Allergol Immunopathol
(Madr). 44:177–188. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nogueira JC and Goncalves Mda C:
Probiotics in allergic rhinitis. Braz J Otorhinolaryngol.
77:129–134. 2011.(In Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ouyang W, Ranganath SH, Weindel K,
Bhattacharya D, Murphy TL, Sha WC and Murphy KM: Inhibition of Th1
development mediated by GATA-3 through an IL-4-independent
mechanism. Immunity. 9:745–755. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang DH, Cohn L, Ray P, Bottomly K and
Ray A: Transcription factor GATA-3 is differentially expressed in
murine Th1 and Th2 cells and controls Th2-specific expression of
the interleukin-5 gene. J Biol Chem. 272:21597–21603. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Szabo SJ, Kim ST, Costa GL, Zhang X,
Fathman CG and Glimcher LH: Pillars article: A novel transcription
factor, T-bet, directs Th1 lineage commitment. Cell. 2000. 100:
655–669. J Immunol. 194:2961–2975. 2015.PubMed/NCBI
|
|
36
|
Chen Z, Lin F, Gao Y, Li Z, Zhang J, Xing
Y, Deng Z, Yao Z, Tsun A and Li B: FOXP3 and RORγt: Transcriptional
regulation of treg and Th17. Int Immunopharmacol. 11:536–542. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kündig TM and Bachmann MF:
Allergen-specific immunotherapy: Regulatory T cells or
allergen-specific IgG? Hum Vaccin. 6:673–675. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nouri-Aria KT and Durham SR: Regulatory T
cells and allergic disease. Inflamm Allergy Drug Targets.
7:237–252. 2008. View Article : Google Scholar : PubMed/NCBI
|
